Bronchopulmonary cancer, antiphospholipid syndrome and coagulation disorders;Cancer bronchique, syndrome des antiphospholipides et pathologie de la coagulation

Revue de Medecine Interne

Volumn 20, Issue 8, 1999, Pages 696-700

  Jullien, V ^a   Heudier, P ^a   Carre Y ^b   Peyrade, F ^a   Taillan, B ^a   Tchiknavorian, X ^a   Chevallier, P ^a   Perrin, C ^c   Fuzibet, G ^a   Dujardin, P ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b Service d'Endocrinologie   (France)

^c PASTEUR HOSPITAL   (France)

Author keywords

Adrenal hemorrhage; Antiphospholipid syndrome; Bronchopulmonary cancer; Coagulation

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADRENAL HEMORRHAGE; ADRENAL INSUFFICIENCY; ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; HUMAN; LUNG CANCER; MALE; METASTASIS; PARANEOPLASTIC SYNDROME; PATHOGENESIS; THROMBOSIS; TUMOR GROWTH;

EID: 0033178203     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(99)80490-1     Document Type: Article

References (22)

1. Stasi R, Stipa M, Masi M. Antiphospholipid antibodies: Prevalence, clinical significance and correlation to cytokine levels in acute myeloïde leukemia and non hodgkin's lymphoma. Thromb Haemostasis 1993 ; 70 : 568-72.
2. Kozlowski CL, Johnson MJ, Gorst DW, Willey RF. Lung cancer, imune thrombocytopenia and the lupus inhibitor. Postgrad Med J 1987 ; 63 : 793-4.
3. Shaukat MN, Hughes P. Recurrent thrombosis and anticardiolipin antibodies associated with adenocarcinoma of the lung. Postgrad Med J 1990 ; 66 : 316-5.
4. Tucker SC. Mesothelioma associated antiphospholipid antibody syndrome presenting with cutaneous infarction and neuropathy. Br J Dermatol 1998 ; 138 : 1092-4.
5. Horusitzky A, Schaetz A, Aertz J, Brice P, Olivero JP, Raguin G. Hémorragie bilatérale des surrénales et syndrome des antiphospholipides révélant un cancer. Ann Intern Med 1996 ; 147 : 64-6.
6. Ruffatti A. Antiphospholipid antibody syndrome associated with ovarian cancer. A new paraneoplastic syndrome? J Rheumatol 1994 ; 21 : 2162-3.
7. Papagiannis A, Cooper A, Banks J. Pulmonary embolism and lupus anticoagulant in a woman with renal cell carcinoma. J Urol 1994 ; 152 : 941-2.
8. Malnick S, Sthoeger Z, Attali M, Geltner D. Anticardiolipin antibodies associated with hypernephroma. Eur J Med 1993 ; 2 : 308-9.
9. Schved JF. A prospective study on the occurence of antiphospholipide antibody syndrome: The Montpellier antiphospholipid study. Haemostasis 1994 ; 24 : 175-82.
10. Christofilis MA, Silvestre-Aillaud P, Piquet P, Aillaud MC, Vialettes B. Insuffisance surrénalienne et syndrome des antiphospholipides. Ann Endocrinol 1994 ; 55 : 283-7.
11. Le Thi Huong DU, Wechsler B, Piette JC, Doumith R, Bellin MF, Papo T, et al. Syndrome des antiphospholipides. Une nouvelle cause d'hémorragie bilatérale des surrénales. Presse Méd 1993 ; 22 : 249-54.
12. Alperin N, Babu S, Weinstein A. Acute adrenal insufficiency and the antiphospholipid syndrome. Ann Intern Med 1989 ; 111 : 950.
13. Hoeffel C, Legmann P, Luton JP, Chapuis JP, Fayet-Bonnin P. Spontaneous adrenal hemorrhage: Computerized tomography and magnetic resonnance imaging findings in 8 cases. J Urol 1995 ; 154 : 1647-51.
14. Tauveron I, Mosnier-Pudar H, Escourolle H, Bertagna X, Bonnin A, Luton JP. Formation tumorale surrénalienne bilatérale, évolution spontanée régressive. Presse Méd 1992 ; 21 : 515-8.
15. Lebeau B, Chastang C, Brechot JM, Capron F, Dautzenberg B, Delaisements C, et al. Subcutaneous heparin treatment increases survival in small cell lung cancer. Cancer 1994 ; 74 : 38-45.
16. Zacharski LR, Henderson WG, Rickles FR. Effects of warfarin on survival in small cell carcinoma of the lung. JAMA 1981 ; 245 : 831.
17. Zacharski LR, Costantini V, Wojtukiewicz MZ, Memoli VA, Kudryl BJ. Anticoagulants as cancer therapy. Semin Oncol 1990 ; 17 : 217.
18. Bréchot JM, Conard J, Samama M. Coagulation et cancers bronchopulmonaires. Rev Mal Respir 1992 ; 9 : 375-84.
19. Ornstein DL, Costantini V, Zacharski LR, Memoli VA, Hunt J, Kisiel W, et al. Coexistent macrophage procoagulant and tumor cell plasminogen activator in primary squamous cell and adenocarcinoma of the lung. Blood 1989 ; 74 Suppl 1 : 292a.
20. Zacharsky LR, Moritz TE, Baczek LA, Rickles FR, Edwards RL, Forman WB, et al. Effect of RA-233 (Mopidamole) on survival in carcinoma of the lung and the colon. Final report of VA cooperative study 188. J Natl Cancer Inst 1988 ; 80 : 90-7.
21. Schneider B, Geser C, Feuerer W. Effect of anticoagulant traitement with RA-233 (Mopidamole) on survival in bronchial cancer. Thromb Haemostasis 1987 ; 58 : 508.
22. Blétry O, Horellou MH, Cosserat J. Conduite à tenir en pré-sence d'un anticoagulant circulant lupique. Méd Thér 1996 ; 2 : 709-16.